SEARCH

SEARCH BY CITATION

References

  • 1
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr.
  • 2
    Sim X, Ali RA, Wedren S, Goh DL, Tan CS, Reilly M, Hall P, Chia KS. Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 2006; 6: 261.
  • 3
    Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, Cheng AL. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 198690.
  • 4
    Parkin DM, Fernández LM. Use of statistics to assess the global burden of breast cancer. Breast J 2006; 12( Suppl 1): S7080.
  • 5
    Bast RC, Jr., Ravdin P, Hayes DF, Bates S, Fritsche H, Jr., Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. American society of clinical oncology tumor markers expert panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 186578.
  • 6
    Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492250.
  • 7
    Dawood S. Triple-negative breast cancer: epidemiology and management options. Drugs 2010; 70: 224758.
  • 8
    Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
  • 9
    Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004; 13: 155868.
  • 10
    Xing P, Li J, Jin F. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 2010; 27: 92631.
  • 11
    Suzuki R, Iwasaki M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Shimazu T, Tsugane S. Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes Control 2010; 21: 178798.
  • 12
    Central Statistical Office of Malaysia. Population Census of Malaysia. Putrajaya: Department of Statistics, 2010.
  • 13
    Ooi Ch, Mastulu W. Epidemiology of cancer in Sarawak 2001–2005. Sarawak Cancer registry, Kuching, Sarawak, 2009.
  • 14
    Cheang MC, Voduc D, Bajdik C, Leung S, Mckinney S, Chia SK, Perou CM, Nielsson TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple negative phenotype. Clin Cancer Res 2008; 14: 1136876.
  • 15
    Lauritsen JM, ed. EpiData Data Entry, Data Management and basic Statistical Analysis System. Odense Denmark, EpiData Association, 2000-2008. Available at: http://www.epidata.dk.
  • 16
    Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research, vol. IV. Descriptive Epidemiology. IARC Scientific Publications No. 128. International Agency for Research on Cancer, 1994. Available at: http://www.iarc.fr/en/publications/pdfs-online/stat/index.php.
  • 17
    Doll R, Payne P, Waterhouse JAH, eds. Cancer Incidence in Five Continents, vol. 1. Geneva: International Union Against Cancer, 1966.
  • 18
    Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report. Cancer 2010; 116: 254959.
  • 19
    Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 2011; 12: 30612.
  • 20
    Porter P. “Westernizing” women's risk? Breast cancer in lower-income countries. N Engl J Med 2008; 358: 2136.
  • 21
    Leete R. Sarawak's human development progress and challenges. UNDP report. Available at: http://cc-sea.org/megananda/data/HDR_COUNTRY/Malaysia_Sarawak_HD.pdf, 2005.
  • 22
    Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, Fu L. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol 2009; 100: 8994.
  • 23
    Tan YO, Han S, Lu YS, Yip CH, Sunpaweravong P, Jeong J, Caguioa PB, Aggarwal S, Yeoh EM, Moon H. The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey. Cancer 2010; 116b: 534857.
  • 24
    Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 451521.
  • 25
    Al-Tamimi DM, Bernard PS, Shawarby MA, Al-Amri AM, Hadi MA. Distribution of molecular breast cancer subtypes in Middle Eastern-Saudi Arabian women: a pilot study. Ultrastruct Pathol 2009; 33: 14150.
  • 26
    Yau TK, Sze H, Soong IS, Hioe F, Khoo US, Lee AW. HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays. Hong Kong Med J 2008; 14: 1305.
  • 27
    Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, Ford JM, Gomez SL. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat 2010; 127: 4718.
  • 28
    Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011; 103: 25063.
  • 29
    Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994; 3: 1735.
  • 30
    Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 2009; 11: R31.
  • 31
    Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109: 12339.
  • 32
    Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 2008; 113: 15216.
  • 33
    Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011; 103: 4707.
  • 34
    Lin CH, Liau JY, Lu YS, Huang CS, Lee WC, Kuo KT, Shen YC, Kuo SH, Lan C, Liu JM, Kuo WH, Chang KJ, et al. Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev 2009; 18: 180714.
  • 35
    Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat 2011; 126: 6718.
  • 36
    Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) 2009; 18: 88393